Anales de la RANM

167 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 Carlos Jiménez Romero, et al. An RANM. 2021;138(02): 157 - 167 ESTADO ACTUAL DEL TRASPLANTE DE PÁNCREAS long-term pancreas function of infection following pancreas-kidney transplantation. Clin Microbiol Infect. 2013; 19: 1132-1139. 35. Lumbreras C, Fernández I, Velosa J, Munn S, Steri- off S, Paya CV. Infectious complications following pancreatic transplantation: incidence, microbio- logical and clinical characteristics, and outcome. Clin Infect Dis. 1995; 20: 514-520. 36. Jiménez C, Lumbreras C, Aguado JM, et al. Suc- cessful treatment of mucor infection after liver or pancreas-kidney transplantation. Transplantation. 2002; 73: 476-480. 37. Marcacuzco A, Jiménez-Romero C, Manrique A, et al. Outcome of patients with hemodialysis under- going simultaneous pancreas-kidney transplanta- tion. Clin Transplant. 2018; 32: e13268. 38. Freise CE, Hirose R, Feng S, et al. Minimal re- jection with a steroid sparing protocol in simul- taneous pancreas kidney transplantation. Am J Transplant. 2002; 2(Suppl.3): 203. 39. Vendrame F, Hopfner YY, Diamantopoulos S, et al. Risk factors for type 1 diabetes recurrence in im- munosuppressed recipients of simultaneous pan- creas-kidney transplants. Am J Transplant. 2016; 16: 235-245. 40. Esmeijer K, Hoogeveen EK, van den Boog PJM, et al. Superior long-term survival for simultaneous pancreas-kidney transplantation as renal replace- ment therapy: 30-year follow-up of a nationwide cohort. Diabetes Care. 2020; 43: 321-328. 41. Sutherland DER, Gruessner RWG, Dunn DL, et al. Lessons learned from more than 1.000 pancreas transplants at a single institution. Ann Surg. 2001; 233: 463-501. 42. Navarro X, Sutherland DER, Kennedy WR. Long term effects of pancreatic transplantation on dia- betic neuropathy. Ann Neurol. 1997; 42: 727-736. 43. Jukema JW, Smets YF, van der Pijl JW, et al. Impact of simultaneous pancreas and kidney transplanta- tion on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetes. Diabetes. 2002; 25: 906-911. 44. Elliott MD, Kapoor A, Parker MA, et al. Improve- ment in hypertension in patients with diabetes me- llitus after kidney/pancreas transplantation. Circu- lation. 2001; 104: 563-569. 45. Ulbig M, Kampik A, Thurau S, et al. Long-term follow-up of diabetic retinopathy for up to 71 months after combined renal and pancreatic trans- plantation. Graefe´s Arch Clin Exp Ophthalmol. 1991; 229: 242-245. 46. Voglová B, Hladiková Z, Nemétová L, et al. Early worsening diabetic retinopathy after simultaneous pancreas and kidney transplantation – Myth or re- ality? Am J Transplant. 2020; 20: 2832-2841. 47. Nathan DM, Fogel H, Norman D, et al. Long-term metabolic and quality of life results with pancrea- tic/renal transplantation in insulin-dependent dia- betes mellitus. Transplantation. 1991; 52: 85-91. 48. Gross CR, Limwattananon C, Matthees B, et al. Im- pact of transplantation on quality of life in patients with diabetes and renal dysfunction. Transplanta- tion. 2000; 70: 1736-1746. 49. Tang J, Gulyani A, Hewawasam E, et al. Pregnancy outcomes for simultaneous pancreas-kidney trans- plant recipients versus kidney transplant recipi- ents. Clin Transplant. 2021; 35: e14151. DECLARACIÓN DE TRANSPARENCIA Los autores/as de este artículo declaran no tener ningún tipo de conflicto de intereses respecto a lo expuesto en el presente trabajo. Si desea citar nuestro artículo: Jiménez C, Moreno E, Manrique A, Marcacuzco A, Caso O, Justo I. Estado actual del trasplante de páncreas. Experiencia del Hospital Doce de Octubre. An RANM. 2021;138(02): 157– 167. DOI: 10.32440/ ar.2021.138.02. rev06

RkJQdWJsaXNoZXIy ODI4MTE=